🧬 $CUE strengthens its board as it advances toward late-stage development.
The company added Daniel Camardo and Viola Meehan to its Board of Directors, bringing deep experience in biotech, commercialization, operations, and finance.
✅ Stronger leadership team
✅ Added commercialization expertise
✅ Positioned to support growth of its anti-IgE and immunology pipeline
As Cue moves its programs forward, management is building the team needed for the next phase of growth.
Communicated Disclaimer - https://t.co/8iaypikMnv